Cargando…
Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis
Coagulation factor XI (FXI) promotes fibrin formation and inhibits fibrinolysis. Elevated plasma FXI levels, limited to a single measurement, are associated with a higher thrombotic risk. Our case–control study aimed to identify the effect of persistently increased plasma FXI levels on the risk of d...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420025/ https://www.ncbi.nlm.nih.gov/pubmed/37568292 http://dx.doi.org/10.3390/jcm12154890 |
_version_ | 1785088673299038208 |
---|---|
author | Spiezia, Luca Forestan, Chiara Campello, Elena Simion, Chiara Simioni, Paolo |
author_facet | Spiezia, Luca Forestan, Chiara Campello, Elena Simion, Chiara Simioni, Paolo |
author_sort | Spiezia, Luca |
collection | PubMed |
description | Coagulation factor XI (FXI) promotes fibrin formation and inhibits fibrinolysis. Elevated plasma FXI levels, limited to a single measurement, are associated with a higher thrombotic risk. Our case–control study aimed to identify the effect of persistently increased plasma FXI levels on the risk of deep vein thrombosis (DVT). All patients evaluated between January 2016 and January 2018 for a first episode of proximal DVT of the lower extremity were considered for enrolment. Plasma FXI levels were measured at least 1 month after the discontinuation of anticoagulant treatment (T1). The patients with increased plasma FXI levels (>90th percentile of controls) were tested again 3 months later (T2). Among the 200 enrolled patients (M/F 114/86, age range 26–87 years), 47 patients had increased plasma FXI levels at T1 and16 patients had persistently increased plasma FXI levels at T2. The adjusted odds ratio for DVT was 2.4 (95% CI, 1.3 to 5.5, p < 0.001) for patients with increased FXI levels at T1 and 5.2 (95% CI, 2.3 to 13.2, p < 0.001) for patients with persistently high FXI levels at T2. Elevated FXI levels constitute a risk factor for deep vein thrombosis, and this risk nearly doubled in patients with persistently increased plasma FXI levels. Larger prospective studies are needed to confirm our findings. |
format | Online Article Text |
id | pubmed-10420025 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104200252023-08-12 Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis Spiezia, Luca Forestan, Chiara Campello, Elena Simion, Chiara Simioni, Paolo J Clin Med Article Coagulation factor XI (FXI) promotes fibrin formation and inhibits fibrinolysis. Elevated plasma FXI levels, limited to a single measurement, are associated with a higher thrombotic risk. Our case–control study aimed to identify the effect of persistently increased plasma FXI levels on the risk of deep vein thrombosis (DVT). All patients evaluated between January 2016 and January 2018 for a first episode of proximal DVT of the lower extremity were considered for enrolment. Plasma FXI levels were measured at least 1 month after the discontinuation of anticoagulant treatment (T1). The patients with increased plasma FXI levels (>90th percentile of controls) were tested again 3 months later (T2). Among the 200 enrolled patients (M/F 114/86, age range 26–87 years), 47 patients had increased plasma FXI levels at T1 and16 patients had persistently increased plasma FXI levels at T2. The adjusted odds ratio for DVT was 2.4 (95% CI, 1.3 to 5.5, p < 0.001) for patients with increased FXI levels at T1 and 5.2 (95% CI, 2.3 to 13.2, p < 0.001) for patients with persistently high FXI levels at T2. Elevated FXI levels constitute a risk factor for deep vein thrombosis, and this risk nearly doubled in patients with persistently increased plasma FXI levels. Larger prospective studies are needed to confirm our findings. MDPI 2023-07-25 /pmc/articles/PMC10420025/ /pubmed/37568292 http://dx.doi.org/10.3390/jcm12154890 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Spiezia, Luca Forestan, Chiara Campello, Elena Simion, Chiara Simioni, Paolo Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis |
title | Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis |
title_full | Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis |
title_fullStr | Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis |
title_full_unstemmed | Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis |
title_short | Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis |
title_sort | persistently high levels of coagulation factor xi as a risk factor for venous thrombosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420025/ https://www.ncbi.nlm.nih.gov/pubmed/37568292 http://dx.doi.org/10.3390/jcm12154890 |
work_keys_str_mv | AT spiezialuca persistentlyhighlevelsofcoagulationfactorxiasariskfactorforvenousthrombosis AT forestanchiara persistentlyhighlevelsofcoagulationfactorxiasariskfactorforvenousthrombosis AT campelloelena persistentlyhighlevelsofcoagulationfactorxiasariskfactorforvenousthrombosis AT simionchiara persistentlyhighlevelsofcoagulationfactorxiasariskfactorforvenousthrombosis AT simionipaolo persistentlyhighlevelsofcoagulationfactorxiasariskfactorforvenousthrombosis |